Search Results
Results found for "Ross Cheloha"
Posts (89)
- Dr. Ross Bathgate becomes Scientific co-founder of LASEREDD Therapeutics
I’m happy to share that I’m starting a new position as Scientific co-founder LASEREDD Therapeutics" Ross
- 📰 GPCR Weekly News, June 5 to 11, 2023
Ines Liebscher, Ross Cheloha and Silvio Gutkind.
- 📰 GPCR Weekly News, May 27 to June 2, 2024
Canonical chemokine receptors as scavenging “decoys” Shivani Sachdev, Brendan Creemer, Thomas Gardella, and Ross Cheloha for their work on Highly biased agonism for GPCR ligands via nanobody tethering Elk Kossatz,
Other Pages (29)
- Dr. Ross Cheloha | Dr. GPCR Ecosystem
Ross Cheloha About this episode Dr. Ross Cheloha is an Investigator at the National Institutes of Health in the Laboratory of Bioorganic Ross and I chatted about his work and transition to an independent investigator; join me to learn more Cheloha’s work. Dr. Ross Cheloha on the web NIDDK Cheloha Lab Google Scholar LinkedIn Twitter ResearchGate Dr.
- Pharmacological and Genetic Preclinical Models of Ghrelin Receptor Functional Selectivity to Investigate Metabolic Disease Pathophysiology
Pathophysiology Date & Time Friday, November 3rd / 9:45 AM Abstract Coming Soon Authors and Affiliations Gross About Joshua Gross "I am a neuropharmacologist interested in exploiting GPCR biased signaling to design pharmacotherapies that improve efficacy and minimize side effects for diet-induced metabolic diseases. " Josh Gross
- Dr. Rosie Dawaliby | Dr. GPCR Ecosystem
Rosie Dawaliby About Dr. Rosie Dawaliby "I’m an expert in early-stage drug discovery, targeting membrane proteins, especially Rosie Dawaliby on the web LinkedIn Dr.
